BackCelularity- Warrants (16/07/2026) Overview
Celularity Inc - Warrants (16/07/2026)

Celularity- Warrants (16/07/2026) Return on Equity

Celularity- Warrants (16/07/2026) (CELUW) has a ROE of 240.96%, above the Healthcare sector average of 20.86%.

Get informed when a big investor buys or sells

+ Follow

ROE

240.96%

Return on Equity

240.96%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Celularity- Warrants (16/07/2026) (CELUW) FAQ

As of the most recent data, CELUW shows a ROE of 240.96%. That is above the Healthcare sector average of 20.86%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 20.86%. Celularity- Warrants (16/07/2026) is at 240.96%, which is higher that average. That is roughly 1055.3% above the sector mean. Use the comparison chart on this page to see how CELUW stacks up against individual peers as well.

Check the historical chart to see whether CELUW's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Celularity- Warrants (16/07/2026) with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Celularity- Warrants (16/07/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 240.96%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 20.86%, while CELUW is at 240.96%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.